Published in Blood on November 01, 1992
Thrombophilia and the surgeon. Ann R Coll Surg Engl (1996) 1.06
Antithrombin III: summary of first database update. Nucleic Acids Res (1994) 0.76
Year in review 2005: Critical Care - resource management. Crit Care (2006) 0.75
The anticoagulant effect of PGI2S and tPA in transgenic umbilical vein endothelial cells is linked to up-regulation of PKA and PKC. Int J Mol Sci (2014) 0.75
Unusual causes of small-bowel obstruction. J R Soc Med (2000) 3.31
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest (2001) 3.24
Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2001) 2.62
Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood (1999) 2.08
Is there a problem with long-term use of sumatriptan in migraine. BMJ (1994) 1.80
Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem (2000) 1.58
Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity. Blood (1992) 1.41
Characterization of the stress-inducing effects of homocysteine. Biochem J (1998) 1.34
Import of precursor proteins into mitochondria: site of polypeptide unfolding. J Biol Chem (1990) 1.11
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate. J Thromb Haemost (2012) 1.07
An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition. Thromb Haemost (1993) 1.05
Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J Leukoc Biol (1997) 1.05
Mitochondrial matrix localization of a protein altered in mutants resistant to the microtubule inhibitor podophyllotoxin. Eur J Cell Biol (1987) 1.01
Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes. J Biol Chem (1997) 1.00
A signal sequence domain essential for processing, but not import, of mitochondrial pre-ornithine carbamyl transferase. J Cell Biol (1987) 0.93
Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin. Blood (1997) 0.92
Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo. Br J Cancer (2013) 0.92
Hyponatremia and increased exchangeable sodium in chronic obstructive lung disease. Am J Med Sci (1965) 0.90
Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. J Biol Chem (1999) 0.88
Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by regulating endoplasmic reticulum calcium depletion in blood monocytes. J Thromb Haemost (2011) 0.87
Molecular cloning and cell-free expression of mouse antithrombin III. Thromb Haemost (1992) 0.83
A barbourin-albumin fusion protein that is slowly cleared in vivo retains the ability to inhibit platelet aggregation in vitro. Thromb Haemost (2001) 0.82
Regulation of Na+/H+ exchanger gene expression: mitogenic stimulation increases NHE1 promoter activity. Am J Physiol (1998) 0.81
Mutation of any site of N-linked glycosylation accelerates the in vivo clearance of recombinant rabbit antithrombin. Thromb Res (2000) 0.80
Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line. Blood (1996) 0.79
Regulation of ornithine aminotransferase in retinoblastomas. J Biol Chem (1989) 0.79
Localization of the thrombin-binding domain on prothrombin fragment 2. J Biol Chem (1998) 0.78
The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin. Biochem J (1992) 0.78
The clearance of thrombin-antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors. Thromb Haemost (1999) 0.78
Retention of thrombin inhibitory activity by recombinant serpins expressed as integral membrane proteins tethered to the surface of mammalian cells. J Thromb Haemost (2011) 0.78
Radioimmunodetection: technical problems and methods of improvement. Eur J Surg Oncol (1999) 0.78
Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin. Blood (1990) 0.77
Defining the heparin-binding domain of antithrombin. Blood Coagul Fibrinolysis (1994) 0.77
The molecular pathology of inherited human antithrombin III deficiency. Transfus Med Rev (1989) 0.77
Dystrophin isoforms DP71 and DP427 have distinct roles in myogenic cells. Muscle Nerve (1999) 0.77
Identification of hydrophobic residues in the signal sequence of mitochondrial preornithine carbamyltransferase that enhance the rate of precursor import. J Biol Chem (1988) 0.76
Impact of mutations at the P4 and P5 positions on the reaction of antithrombin with thrombin and elastase. Thromb Res (1997) 0.76
Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy. Medicine (Baltimore) (1970) 0.75
Genetic linkage studies in antithrombin-deficient kindreds using a highly polymorphic trinucleotide short tandem repeat (STR) within the human antithrombin gene. Am J Hematol (1994) 0.75
A social worker's observations of runaways at an institution for the mentally retarded. Ment Retard (1970) 0.75
Antithrombin III-Amiens: a new family with an Arg47----Cys inherited variant of antithrombin III with impaired heparin cofactor activity. Am J Hematol (1991) 0.75
Antithrombin III Sudbury: an Ala384----Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis. Thromb Res (1990) 0.75
Complete nucleotide sequence of the cDNA encoding rabbit coagulation factor VII. Thromb Res (1993) 0.75
Inhibition of thrombin by hirudin genetically fused to wild-type or mutant antithrombin. Thromb Res (1996) 0.75
Characterization of a highly polymorphic trinucleotide short tandem repeat within the human antithrombin gene. Thromb Res (1994) 0.75
Effects of antimitotic and antimitochondrial agents on the cellular distribution of microtubules and mitochondria. Cytobios (1990) 0.75
Expression in Escherichia coli of functional precursor to the rat liver mitochondrial enzyme, ornithine carbamyl transferase. Precursor import and processing in vitro. Biochem Biophys Res Commun (1986) 0.75